What is the Impact Factor of Therapeutic Advances in Chronic Disease?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Therapeutic Advances in Chronic Disease is 2.70, ranking in quartile Q3 of Web of Science (SCIE).

Is Therapeutic Advances in Chronic Disease indexed in Web of Science or Scopus?

Yes, Therapeutic Advances in Chronic Disease is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.937 (Q1) and an H-index of 59.

Who publishes Therapeutic Advances in Chronic Disease and what is the Article Processing Charge (APC)?

Therapeutic Advances in Chronic Disease is published by SAGE Publications Inc.. The estimated Article Processing Charge (APC) is approximately $3,320 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Therapeutic Advances in Chronic Disease?

The official ISO-4 abbreviation of Therapeutic Advances in Chronic Disease is "THER ADV CHRONIC DIS". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q1SCImago #5,457Gold OA

Therapeutic Advances in Chronic Disease

Abbreviation (ISO):THER ADV CHRONIC DIS

•

Identifier (ISSN):2040-6223(Print)/2040-6231(Online)

•

Publisher:SAGE Publications Inc.

Official Website Submission Portal Compare

Clarivate IF (2026)

2.7↓ -0.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Therapeutic Advances in Chronic Disease

WoS Q3

Annual Impact Factor Metric

Current (2026):2.7

Scopus SJR & RankScopus Q1

0.937

#5,457

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

59 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

105articles/year

100% Gold OA•69.42% Original Research

Aims & Scope

Therapeutic Advances in Chronic Disease publishes the highest quality peer-reviewed research, reviews and scholarly comment in the drug treatment of all chronic diseases. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers involved in the medical treatment of chronic disease, providing a forum in print and online for publishing the highest quality articles in this area.

Topics Covered (Recognized by AI)

MedicineInternal MedicineBiologyPathologySurgeryPsychologyEndocrinologyChemistryBiochemistryPsychiatryGeneticsPathology & DiseasesImmunologyMathematicsStatisticsGastroenterologyPharmacologyIntensive Care MedicinePhysics

Primary Research Areas

Medicine Medicine (miscellaneous)

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank191/356

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank172/356

IndexSCIE

Category	Index	Rank	Quartile
PHARMACOLOGY & PHARMACY	JCRSCIE	191/356	Q3
PHARMACOLOGY & PHARMACY	JCISCIE	172/356	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

13 year

2026Latest

IF2.7

Articles / Year—

Total Citations—

2025

IF2.8

Articles / Year37

Total Citations89

2024

IF3.3

Articles / Year38

Total Citations194

2023

IF3.5

Articles / Year84

Total Citations695

2022

IF4.97

Articles / Year122

Total Citations2,025

Year	Impact Factor	Articles / Year	Total Citations
2026	2.7	—	—
2025	2.8	37	89
2024	3.3	38	194
2023	3.5	84	695
2022	4.97	122	2,025
2021	5.091	115	2,032
2020	4.257	87	2,538
2019	4.455	58	2,314
2018	4.9	20	1,010
2017	—	19	930
2016	—	19	1,157
2015	—	31	2,210
2014	—	20	1,503

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,457Scopus Q1SCImago Profile

Scopus Coverage:2010-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q1

0.937

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

2.95

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,320 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations833

3-Year Documents243

Citable Documents237

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区PHARMACOLOGY & PHARMACY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Therapeutic Advances in Chronic Disease (abbr: THER ADV CHRONIC DIS, ISSN: 2040-6223) is a peer-reviewed international scholarly journal in the field of Medicine, published by SAGE Publications Inc. in United States. The periodical holds a Journal Impact Factor (JIF) of 2.70, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.937 (Q1), an H-index of 59.

The journal enforces rigorous peer evaluation with an annual output of approximately 105 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,320 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.